Advanced Search

Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2016 June;64(3) > Minerva Cardioangiologica 2016 June;64(3):265-83

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752

Frequency: Bi-Monthly

ISSN 0026-4725

Online ISSN 1827-1618

 

Minerva Cardioangiologica 2016 June;64(3):265-83

CONTEMPORARY ISSUES RELATED TO STEMI MANAGEMENT 

    REVIEWS

Choosing the right stent for patients with ST-segment elevation myocardial infarction: the evidence-based approach

Artur DZIEWIERZ 1, Dariusz DUDEK 2

1 2nd Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland; 2 Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland

Primary percutaneous coronary intervention (PCI) with the implantation of new-generation drug-eluting stents (DES) is the preferred method of reperfusion in ST-segment elevation myocardial infarction (STEMI). More importantly, new-generation DES are recommended as the default option in all clinical conditions and lesion subsets. On the other hand, the interest in fully bioresorbable scaffolds (BRS) implantation, also in the setting of STEMI is growing. Also, dedicated stents technologies, i.e. mesh-covered stents and self-expanding stents may play role in the treatment of STEMI and thrombus containing lesions. This review discusses the evidence for different stent options in STEMI with a proposed selection strategy in contemporary primary PCI.

language: English


FULL TEXT  REPRINTS

top of page